Nω‐Nitro‐L‐arginine Administration Corrects Peripheral Vasodilation and Systemic Capillary Hypotension and Ameliorates Plasma Volume Expansion and Sodium Retention in Portal Hypertensive Rats
Fa‐Yauh Lee, Luis A. Colombato, Agustin Albillos, Roberto J. Groszmann – 1 January 1993 – In portal hypertensive states, peripheral vasodilation leads to sodium retention and plasma volume expansion. Nω‐nitro‐L‐arginine, a specific biosynthesis inhibitor of the vasodilator nitric oxide, has been shown to acutely reverse peripheral vasodilation and the vascular hyporesponsiveness to endogenous and exogenous vasoconstrictors observed in portal hypertensive rats.